Additionally, Luteolin-7-O-glucoside has been shown to activate STAT3-mediated liver cell regeneration, mitigating palmitic acid-induced hepatic injury associated with NAFLD [43,54,55]. Here, STAT3 is linked to metabolic dysfunction-associated steatotic liver disease.